MLYS Competitors & Alternatives
Compare Mineralys Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MLYS
Main Stock$21.07
Tradestie Score
70
Market Cap
$3.09B
Analyst Upside
+119.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.62
|
$2.02B | - | 47 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.58
|
$2.01B | - | 58 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.30
|
$1.97B | - | 56 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.55
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$64.92
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$39.46
|
$1.90B | 26.2 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.10
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.52
|
$1.81B | - | 34 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.83
|
$1.78B | - | 54 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.83
|
$1.78B | - | 53 | Compare |
More MLYS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry